+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurocrine Biosciences Inc - logo
Gynaecology Drugs Market Report 2023-2033 - Product Thumbnail Image

Gynaecology Drugs Market Report 2023-2033

  • Report
  • February 2023
  • 340 Pages
  • Global
From
Global Dementia and Movement Disorder Treatment Market - Product Thumbnail Image

Global Dementia and Movement Disorder Treatment Market

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Endometriosis Drugs: Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs: Global Strategic Business Report

  • Report
  • December 2023
  • 191 Pages
  • Global
From
Global Endometriosis Treatment Market by Drug Type (GnRH Analogues, LNR-IUDS, NSAIDs), Treatment Type (Hormonal Therapy, Pain Management), Distribution Channel - Forecast 2023-2030 - Product Thumbnail Image

Global Endometriosis Treatment Market by Drug Type (GnRH Analogues, LNR-IUDS, NSAIDs), Treatment Type (Hormonal Therapy, Pain Management), Distribution Channel - Forecast 2023-2030

  • Report
  • October 2023
  • 187 Pages
  • Global
From
Rare Neurological Disease Treatment Global Market Report 2023 - Product Thumbnail Image

Rare Neurological Disease Treatment Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
Polycystic Ovarian Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Polycystic Ovarian Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 135 Pages
  • Global
From
Global Adeno-Associated Virus Vector-Based Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Adeno-Associated Virus Vector-Based Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • June 2023
  • 127 Pages
  • Global
From
Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 108 Pages
  • Global
From
Global Endometriosis Treatment Market (2023-2028) by Drug Type, Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - Product Thumbnail Image

Global Endometriosis Treatment Market (2023-2028) by Drug Type, Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis

  • Report
  • July 2023
  • 187 Pages
  • Global
From
Bipolar Disorder (Manic Depression) - Pipeline Insight, 2020 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Uterine Leiomyoma (Uterine Fibroids) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • June 2022
  • 251 Pages
  • Global
From
Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 387 Pages
  • Global
From
Uterine Leiomyoma (Uterine Fibroids) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Uterine Leiomyoma (Uterine Fibroids) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • July 2021
  • 232 Pages
  • Global
From
Uterine Leiomyoma (Uterine Fibroids) Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Uterine Leiomyoma (Uterine Fibroids) Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 226 Pages
  • Global
From
Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • November 2020
  • 111 Pages
  • Global
From
Endometriosis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Endometriosis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 308 Pages
  • Global
From
2019 Metrorrhagia (Abnormal Uterine Bleeding) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Metrorrhagia (Abnormal Uterine Bleeding) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 54 Pages
  • Global
From
2019 Uterine Leiomyoma (Uterine Fibroids) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Uterine Leiomyoma (Uterine Fibroids) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 165 Pages
  • Global
From
Neurocrine Biosciences Inc (NBIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Neurocrine Biosciences Inc (NBIX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • November 2023
  • 89 Pages
From
Loading Indicator